
|Videos|July 24, 2021
Surgical updates for Bausch + Lomb
Chuck Hess shares an update on Bausch + Lomb's latest developments in surgical technology, as well as how the company has adapted its operations during the pandemic.
Advertisement
Chuck Hess, vice president and general manager, U.S. Surgical (Bausch +Lomb), shares an update on Bausch + Lomb's latest developments in surgical technology — including ClearVisc™, a dispersive ophthalmic viscosurgical device — as well as how the company has adapted its operations during the pandemic.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
2
4DMT and Otsuka Pharmaceutical partner on 4D-150 in the greater Asia-Pacific region
3
AAVantgarde Bio closes $141 million Series B financing round
4


















































.png)


